Premium
Enhanced NAD(P)H:Quinone Reductase Activity Prevents Glutamate Toxicity Produced by Oxidative Stress
Author(s) -
Murphy Timothy H.,
Long Mary J.,
Coyle Joseph T.
Publication year - 1991
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.1991.tb02019.x
Subject(s) - nad+ kinase , oxidative stress , glutamate receptor , toxicity , chemistry , quinone , reductase , biochemistry , oxidative phosphorylation , pharmacology , enzyme , biology , organic chemistry , receptor
Glutamate toxicity in the N18‐RE‐105 neuronal cell line results from the inhibition of high‐affinity cystine uptake, which leads to a depletion of glutathione and the accumulation of oxidants. Production of superoxides by one‐electron oxidation/reduction of quinones is decreased by NAD(P)H:quinone reductase, an enzyme with DT‐diaphorase activity. Using glutamate toxicity in N18‐RE‐105 cells as a model of neuronal oxidative stress, we report that the degree of glutamate toxicity observed is inversely proportional to quinone reductase activity. Induction of quinone reductase activity by treatment with t ‐butylhydroquinone reduced glutamate toxicity by up to 80%. In contrast, treatment with the quinone reductase inhibitor dicumarol potentiated the toxic effect of glutamate. Measurement of cellular glutathione indicates that increases in its levels are not responsible for the protective effect of t ‐butylhydroquinone treatment. Because many types of cell death may involve the formation of oxidants, induction of quinone reductase may be a new strategy to combat neurodegenerative disease.